Breast cancer recurrence after prior definitive multimodality treatment is an increasingly common clinical situation faced by practitioners, with long-term new primary or recurrent non-metastatic locoregional recurrence developing not infrequently over 10 years following initial treatment.

This is a case-based panel activity, with a surgeon, a medical oncologist and a radiation oncologist. Each speaker reviews the current and ongoing studies addressing treatment de-intensification in their area of expertise.

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipl

There are multiple new developments in the treatment of breast cancer patients with radiation therapy, as well as ongoing developments in the use of breast IMRT. Practicing clinicians need to stay informed to improve outcomes among breast cancer patients.  

The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.

This activity involves three discussants using case-based presentations to review challenging areas of breast cancer management. The first discussant examines the options for treating patients with recurrent breast cancer.

This activity involves three discussants using case-based presentations to review challenging areas of breast cancer management. The first discussant examines the options for treating patients with recurrent breast cancer.

This activity involves three discussants using case-based presentations to review recent advances in breast cancer treatment. The first discussant addresses when to treat early stage breast cancer patients, including a review of the recent ASTRO APBI guidelines and the IDEA and Lumina 1 trial.

This journal activity provides a summary of the current state of Early-Stage Breast Cancer radiotherapy treatments and an overview of the clinical data that can be used to create a more personalized radiotherapeutic management of patients based on molecular profiling and risk stratification.

Breast cancer is the most diagnosed cancer in women. The most commonly diagnosed form of breast cancer in the United States is early-stage breast cancer, for which there are outstanding outcomes.

Pages

Subscribe to RSS - Breast